Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 15/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TCF4 | P15884 | 1/20 | 0.39 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14620561 | 0.97 | CYP3A4 (0.46) | CYP3A4 | |
| SCHEMBL14619991 | 0.92 | CYP3A4 (0.43) | CYP3A4MEN1KMT2A | |
| SCHEMBL14620559 | 0.92 | MEN1 (0.48) | CYP3A4MEN1KMT2ANPC1ALDH1A1 | |
| SCHEMBL14620396 | 0.91 | MEN1 (0.49) | CYP3A4MEN1KMT2AALDH1A1 | |
| SCHEMBL748026 | 0.89 | MEN1 (0.40) | CYP3A4MEN1KMT2AALDH1A1TCF4 | |
| SCHEMBL747436 | 0.89 | MEN1 (0.42) | CYP3A4MEN1KMT2AALDH1A1 | |
| SCHEMBL14629369 | 0.89 | CYP3A4 (0.38) | CYP3A4MEN1KMT2ANPC1ALDH1A1 | |
| SCHEMBL14629365 | 0.89 | CYP3A4 (0.42) | CYP3A4 | |
| SCHEMBL747232 | 0.88 | MEN1 (0.43) | CYP3A4MEN1KMT2AALDH1A1 | |
| SCHEMBL748974 | 0.88 | MEN1 (0.43) | CYP3A4MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070021425-A1 | Reverse-turn mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021425-A1 | Reverse-turn mimetics and method relating thereto | WNT1, APC, WNT3 | CYP3A4 4757/4885MEN1 336/4885KMT2A 4111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.